Usuda Y, Sekine O
Jpn J Antibiot. 1985 Apr;38(4):1141-6.
Serum and/or urine levels of cefaclor (CCL) were studied in 4 patients during the therapy with CCL. In patients with severely impaired renal function, moderately higher serum and urine levels of CCL persisted, serum half-lives of CCL were moderately prolonged and urinary excretion of CCL slightly decreased. Although dosage modification of CCL is necessary in patients with renal dysfunction, multiple doses of 250 mg every 8 hours may be safe and effective even in patients with impaired renal function.
在4例接受头孢克洛(CCL)治疗的患者中研究了其血清和/或尿液水平。在肾功能严重受损的患者中,CCL的血清和尿液水平持续略高,CCL的血清半衰期适度延长,CCL的尿排泄略有减少。尽管肾功能不全患者需要调整CCL的剂量,但即使是肾功能受损的患者,每8小时多次服用250mg可能也是安全有效的。